CT-1812 CAS:1802632-22-9
CT-1812
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-C-2100 | 50mg | 925.00 | + Add to cart  | 
																					|
| R-C-2100 | 100mg | 1250.00 | + Add to cart  | 
																					|
| R-C-2100 | 200mg | 1750.00 | + Add to cart  | 
																					|
| 
										 | 
								||||
Product description
							CT-1812 is a first-in-class,orally available sigma-2/PGRMC1 antagonist(alpha beta oligomer receptor antagonist),is being developed by Cognition.sCT-1812 is a novel therapeutic candidate for Alzheimer is disease.
| Appearance | N/A | 
|---|---|
| Molecular Weight | N/A | 
| purity | >95% | 
| PDI by GPC | <1.5 | 
| Solubility | N/A | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 3 weeks | 
| Stability | 2 years | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds---CT-1812 
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

